Coming soon

At-home blood testing

Join the waitlist
Belle Cares

We're giving $50,000.

Nominate

What is compounded semaglutide? How compounding works

Compounded semaglutide is prepared by a licensed pharmacist for one patient. How compounding works, what the FDA says, and how to check a pharmacy.

Written by the Belle clinical teamMedically reviewed by Dr. Patrick Taylor, MD

What compounded semaglutide is

Compounded semaglutide is a prescription medication that a licensed pharmacist prepares for one patient at a state-licensed pharmacy. Compounded drugs are not FDA approved, which means the agency does not review their safety, effectiveness or quality before they are marketed.

Compounded medications are not FDA approved finished products. A licensed provider determines eligibility.

The FDA describes compounding as a practice in which a licensed pharmacist, or a licensed physician, combines, mixes or alters ingredients of a drug to create a medication tailored to the needs of an individual patient. The agency also notes that while compounded drugs can serve an important medical need for certain patients, they also may pose risks to patients.

Separately, there are two FDA-approved semaglutide products. Per its DailyMed label, Wegovy is a glucagon-like peptide-1 (GLP-1) receptor agonist, and Wegovy injection is indicated in combination with a reduced calorie diet and increased physical activity to reduce the risk of major adverse cardiovascular events in adults with established cardiovascular disease and either obesity or overweight, and to reduce excess body weight and maintain weight reduction long term in adults and pediatric patients aged 12 years and older with obesity.

Per its DailyMed label, Ozempic is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus, to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes mellitus and established cardiovascular disease, and to reduce the risk of sustained eGFR decline, end-stage kidney disease and cardiovascular death in adults with type 2 diabetes mellitus and chronic kidney disease.

If your question is whether compounded semaglutide is the same as Ozempic, or whether a pen is different from a vial, those belong in a separate guide: compounded semaglutide vs Wegovy and Ozempic.

How compounding works, from prescription to vial

  1. A licensed provider evaluates you and writes a prescription. The FDA tells patients to obtain a prescription from their doctor and fill the prescription at a state-licensed pharmacy.
  2. The prescription is sent to a state-licensed pharmacy rather than picked off a shelf.
  3. A licensed pharmacist combines, mixes or alters ingredients of a drug to create a medication tailored to the needs of an individual patient.
  4. The medication is dispensed. The FDA says compounders offer semaglutide injectable products in various containers and packaging, including multiple-dose vials and prefilled syringes. With a multiple-dose vial, you measure each dose yourself.

Oversight works differently than it does for approved products. The FDA states that state boards of pharmacy generally have primary responsibility for the day-to-day oversight of state-licensed pharmacies. That is why the license lookup described further down matters so much.

If your prescription starts with an online visit, how peptide telehealth works walks through the same sequence from intake to delivery.

Why a prescriber might choose a compounded medication

The FDA's own examples are narrow. In its compounding questions and answers, the agency explains that a drug may be compounded for a patient who cannot be treated with an FDA-approved medication, and gives two examples:

The FDA also states that compounded drugs should only be used in patients whose medical needs cannot be met by an FDA-approved drug. Whether that applies to you is a judgment for a licensed provider who has reviewed your history, not something to decide from an article.

Is compounded semaglutide a generic?

No. The FDA answers this directly: a generic drug is approved by the FDA and meets all of the requirements of that approval pathway, including establishing therapeutic equivalence to a brand name drug, while a compounded drug is not approved by the FDA.

Generic drugs and compounded drugs, as the FDA describes them
Generic drugCompounded drug
FDA approvalApproved by the FDANot approved by the FDA
Therapeutic equivalence to a brand name drugEstablished as part of approvalNot established
Who it is prepared forA drug marketed broadly after approvalA medication tailored to the needs of an individual patient

Where compounded semaglutide stands with the FDA

Two FDA statements are worth knowing. First, in an update dated February 21, 2025, the FDA determined that the shortage of semaglutide injection products is resolved. Those products had been in shortage since 2022 due to increased demand.

Second, in its page on concerns with unapproved GLP-1 drugs used for weight loss, the FDA states that compounded drugs should only be used in patients whose medical needs cannot be met by an FDA-approved drug, and that patients should obtain a prescription from their doctor and fill it at a state-licensed pharmacy.

It is worth repeating the core point here: compounded drugs are not FDA approved, which means the agency does not review their safety, effectiveness or quality before they are marketed. So if you are asking whether compounded semaglutide is effective, there is no FDA effectiveness review to point to. What the approved products were studied for lives on their own labels, which is covered in compounded semaglutide vs Wegovy and Ozempic.

For a plain reading of the agency's position and what it changes for patients, see what the FDA statement on unapproved GLP-1 drugs means for you.

What is in the vial: the active ingredient form and added ingredients

Check which form the label names

The FDA says it is aware that some semaglutide products sold by compounders may be salt forms, and that these salt forms, including semaglutide sodium and semaglutide acetate, are different active ingredients than are used in the approved drugs. Read your label and see which form it names. If the label does not say, ask the pharmacy before you use the product.

Ask what else is in it

The FDA has also said it is aware that some compounders incorporate additional ingredients into their semaglutide products. That means the contents of one compounder's vial are not assumed from another's. Ask your pharmacy exactly what your vial contains, and bring the answer to your provider.

Belle's compounded semaglutide is prescribed only after a licensed provider reviews your intake. Pricing sits outside this guide: see compounded semaglutide cost, and GLP-1 without insurance if you are paying out of pocket.

Reading the label and measuring a dose

This is where compounded injectables differ most from a product that arrives in one fixed presentation. The FDA notes that product concentrations may vary depending on the compounder, and that a single compounder may offer multiple concentrations of compounded semaglutide products.

The FDA also notes that the instructions accompanying the compounded drug, if provided, may instruct users to administer injections in "units", the volume of which may vary depending on the concentration, rather than in milligrams or milliliters. A unit is a marking on a syringe, not a fixed amount of drug.

The agency has reported receiving adverse event reports, some requiring hospitalization, that may be related to overdoses due to dosing errors with compounded semaglutide injectable products, including dosing errors that resulted from patients measuring and self-administering incorrect doses and from health care providers miscalculating doses.

Practically, the concentration printed on your label, the milligrams per milliliter, is what links a prescribed dose in milligrams to a reading on your syringe. The FDA encourages patients to talk with their health care provider or compounder about how to measure and administer the intended dose. Do that before your first injection and again any time your label changes. For background on how milligram doses and syringe units relate, see the semaglutide dosage chart, then confirm your own plan with your prescriber.

How to check the pharmacy behind your prescription

The FDA has said it is aware of fraudulent compounded semaglutide marketed in the U.S. that contains false information on the product label, and that in some cases the pharmacy identified on the label does not exist. Verifying the pharmacy is a short task with a clear answer.

  1. Look up the pharmacy named on your label in your state board of pharmacy license database. The FDA's BeSafeRx state list links to each state's database. If the pharmacy is not listed, the FDA says you should not use that pharmacy.
  2. Check the website with the National Association of Boards of Pharmacy Safe Site Search Tool, which lets you search a web address to see whether a site is accredited by NABP or not recommended.
  3. Look at the label itself for the red flags the FDA lists: spelling errors, incorrect addresses of the pharmacy, or a pharmacy name on the label that you think might be fraudulent.
  4. Contact the compounder who made the drug or the telehealth platform where you purchased it if you have any questions about the instructions for use or information on the label.

None of this replaces a clinical conversation. Whether a compounded medication is appropriate for you, and how to use it safely, is a decision for a licensed provider who knows your history.

Common questions

What is compounded semaglutide?

It is a prescription medication that a licensed pharmacist prepares for an individual patient at a state-licensed pharmacy. Compounded drugs are not FDA approved, which means the agency does not review their safety, effectiveness or quality before they are marketed.

How does compounding work?

The FDA describes compounding as a licensed pharmacist, or a licensed physician, combining, mixing or altering ingredients of a drug to create a medication tailored to the needs of an individual patient. In practice, a licensed provider evaluates you and writes a prescription, the prescription is filled at a state-licensed pharmacy, a pharmacist prepares it for you, and it is dispensed in a container such as a multiple-dose vial or a prefilled syringe.

Who makes compounded semaglutide?

A licensed pharmacist at a state-licensed pharmacy prepares it for an individual patient with a prescription. The FDA states that state boards of pharmacy generally have primary responsibility for the day-to-day oversight of state-licensed pharmacies, which is why checking the pharmacy's license in your state database matters.

Is compounded semaglutide a generic?

No. The FDA explains that a generic drug is approved by the FDA and meets all of the requirements of that approval pathway, including establishing therapeutic equivalence to a brand name drug, while a compounded drug is not approved by the FDA.

What is in a compounded semaglutide vial?

That depends on the pharmacy, so ask yours directly. The FDA has said it is aware that some compounders incorporate additional ingredients into their semaglutide products, and that product concentrations may vary depending on the compounder, with a single compounder sometimes offering multiple concentrations. Your label and your pharmacy are the sources of truth.

What is semaglutide sodium?

It is a salt form. The FDA has said it is aware that some semaglutide products sold by compounders may be salt forms, and that these salt forms, including semaglutide sodium and semaglutide acetate, are different active ingredients than are used in the approved drugs. Check which form your label names, and ask the pharmacy if it does not say.

How do I know my pharmacy is real?

The FDA has said it is aware of fraudulent compounded semaglutide with false information on the product label, and that in some cases the pharmacy identified on the label does not exist. Look up the pharmacy named on your label in your state board of pharmacy license database through the FDA's BeSafeRx state list and do not use it if it is not listed, check the website with the NABP Safe Site Search Tool, and watch for spelling errors, incorrect pharmacy addresses or a pharmacy name you think might be fraudulent.

Is compounded semaglutide the same as Ozempic?

That comparison is covered in a separate guide, compounded semaglutide vs Wegovy and Ozempic, which also covers pens versus vials. What applies here is that compounded drugs are not FDA approved, so the agency does not review their safety, effectiveness or quality before they are marketed.

Treatments mentioned

Compounded medications are not FDA approved finished products. A licensed provider determines eligibility. Important safety information.

References

  1. Human Drug Compounding, U.S. FDA
  2. Compounding and the FDA: Questions and Answers, U.S. FDA
  3. FDA concerns with unapproved GLP-1 drugs used for weight loss, U.S. FDA
  4. FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize, U.S. FDA
  5. FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products, U.S. FDA
  6. Locate a State-Licensed Online Pharmacy (BeSafeRx), U.S. FDA
  7. Verify a pharmacy, National Association of Boards of Pharmacy
  8. Wegovy prescribing information (DailyMed), NIH DailyMed
  9. Ozempic prescribing information (DailyMed), NIH DailyMed

Talk to a licensed provider about your options

Online visit, provider review, and delivery to your door if you qualify.

Start your online visit